Associated Papers
Genetic investigations on singleton school aged children reveal novel variants and new candidate genes for hearing loss.
Khan H et al.
Scientific Reports, 2024
Structure of GPR101-Gs enables identification of ligands with rejuvenating potential.
Yang Z et al.
Nature Chemical Biology, 2024
KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas.
Chasseloup F et al.
European Journal of Endocrinology, 2024
Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R et al.
Medicina (kaunas, Lithuania), 2023
Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report.
Bao XD et al.
Bmc Endocrine Disorders, 2022
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis.
Trivellin G et al.
Endocrine-related Cancer, 2020
Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S et al.
European Journal of Endocrinology, 2019
Hypermethylator Phenotype and Ectopic GIP Receptor in GNAS Mutation-Negative Somatotropinomas.
Hage M et al.
The Journal of Clinical Endocrinology and Metabolism, 2019
Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S et al.
The Journal of Endocrinology, 2019
Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.
Hou ZS et al.
Progress in Molecular Biology and Translational Science, 2019
An update on the genetics of benign pituitary adenomas in children and adolescents.
Hannah-Shmouni F et al.
Current Opinion in Endocrine and Metabolic Research, 2018
Genomic Alterations and Complex Subclonal Architecture in Sporadic GH-Secreting Pituitary Adenomas.
Hage M et al.
The Journal of Clinical Endocrinology and Metabolism, 2018
Screening for germline KCNQ1 and KCNE2 mutations in a set of somatotropinoma patients.
Iivonen AP et al.
Endocrine Connections, 2018
Gain-of-function mutations in G-protein-coupled receptor genes associated with human endocrine disorders.
Fukami M et al.
Clinical Endocrinology, 2018
Genomic Alterations in Sporadic Pituitary Tumors.
Bi WL et al.
Current Neurology and Neuroscience Reports, 2018
Genetic Aspects of Pituitary Adenomas.
Marques P et al.
Endocrinology and Metabolism Clinics of North America, 2017
Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
Iacovazzo D et al.
Expert Review of Endocrinology & Metabolism, 2017
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
Ferraù F et al.
Endocrine, 2016
Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery.
Nagata K et al.
Journal of Structural and Functional Genomics, 2016
Genetic and clinical characteristics of Japanese patients with sporadic somatotropinoma.
Matsumoto R et al.
Endocrine Journal, 2016
Copy number variation analysis detects novel candidate genes involved in follicular growth and oocyte maturation in a cohort of premature ovarian failure cases.
Tšuiko O et al.
Human Reproduction (oxford, England), 2016
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
Iacovazzo D et al.
Acta Neuropathologica Communications, 2016
GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.
Castinetti F et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 2016
Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
Lecoq AL et al.
European Journal of Endocrinology, 2016
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.
Daly AF et al.
Endocrine-related Cancer, 2016
Multiallelic Positions in the Human Genome: Challenges for Genetic Analyses.
Campbell IM et al.
Human Mutation, 2016
Genomic insights into growth and its disorders: an update.
de Bruin C et al.
Current Opinion in Endocrinology, Diabetes, and Obesity, 2016
Gigantism, acromegaly, and GPR101 mutations.
Daly AF et al.
The New England Journal of Medicine, 2015
Gigantism, acromegaly, and GPR101 mutations.
Roohi J
The New England Journal of Medicine, 2015
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
Trivellin G et al.
The New England Journal of Medicine, 2014
Genetics of gigantism and acromegaly.
Hannah-Shmouni F et al.
Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 0
Gigantism: X-linked acrogigantism and GPR101 mutations.
Iacovazzo D et al.
Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society, 0